Atlas market file · Equity · United States
Janus Living, Inc.JAN
- Last close
- 29.69
- Change
- -2.62%
- 96-bar range
- 22.76 – 32.83
- As of
- 6 Aug 2026
Janus Living, Inc. is a real estate investment trusts issuer listed as JAN on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 22 weekly closes (+25.81% over the window).
Source rail: Yahoo Finance chart API (JAN). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for JAN. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
JAN public profile
Real estate investment trusts issuer. Janus Living, Inc. is connected to current market context, cited company sources and its retained research file.
Janus Living, Inc. trades as JAN on NYSE. Janus Living, Inc. (JAN) has a latest verified close of 29.69, down 2.62%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files JAN under USA Stocks for browsing.
What changed for Janus Living, Inc. today
Janus Living, Inc. wrapped its March quarter with $200.3 million in revenue and a $6.3 million net profit from the prior year-end, but the latest 10-Q shows the cash-generative giant now reporting a diluted loss of five pence per share while carrying $948.8 million in cash. The numbers are contradictory enough to make an accountant reach for a second coffee: the company can fund its own operations from its balance sheet, yet its headline EPS is still waving in the red. (source: SEC EDGAR 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/2100805/000162828026013633/0001628280-26-000079.htm)
Janus Living’s business model rests on operating assisted-living residences, a sector where state licences are the gatekeepers and Medicare/Medicaid typically won’t cover the tab. The company’s filings stress that assisted-living services are generally non-reimbursable under governmental programmes, which means the cash it collects must come from private payers or joint ventures rather than public coffers. The 424B4 prospectus goes further, noting that assisted-living residences-excluding memory care-are licensed at state level, adding another layer of regulatory friction to scaling. (source: 424B4 filing, https://www.sec.gov/Archives/edgar/data/2100805/000110465926070188/tm2614872-10_424b4.htm)
On the capital side, Janus Living’s balance sheet is the clear star: $4.02 billion in assets against $977.9 million in liabilities, leaving $2.16 billion in stockholders’ equity and $948.8 million in cash and equivalents at 31 March 2026. Operating cash flow clocked in at $33.3 million for the quarter, but the income statement tells a different story-diluted EPS of minus five pence on 263.1 million shares. The optics are neat: strong liquidity, thin leverage, and a balance sheet that could weather a storm. The problem is the income statement, which is still dripping red ink. (source: SEC EDGAR 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/2100805/000162828026013633/0001628280-26-000079.htm)
The company’s June 2026 S-11 filing reminds investors that Janus Living’s share of unconsolidated joint venture revenues is disclosed, yet it does not quantify the contribution in the latest documents, leaving the revenue bridge from private payers to broader scale unproven. The same filing notes that assisted-living services are not reimbursable under Medicare or Medicaid, which helps explain why the cash flow is positive but the net income is not. (source: SEC EDGAR S-11, https://www.sec.gov/Archives/edgar/data/2100805/000110465926068606/tmb-20260331xs11.htm)
The equity plan, referenced in Exhibits 10.4 and 10.5, promises five-year performance-based LTIP units, yet the filings do not tie the incentive metrics to measurable improvements in net income or cash flow coverage ratios. The plan language is polished; the linkage to operating performance is polite. (source: 2026 Equity Plan, Exhibit 10.4, https://www.sec.gov/Archives/edgar/data/2100805/000110465926027908/tm2533329d6_ex10-4.htm; Form of 5-Year Performance-Based LTIP Unit Agreement, Exhibit 10.5, https://www.sec.gov/Archives/edgar/data/2100805/000110465926027908/tm2533329d6_ex10-5.htm)
The share count has been drifting upward, with 263.1 million diluted shares outstanding at quarter-end, a figure that sits awkwardly next to the equity plan’s incentive promises and the company’s still-negative EPS. The optics suggest dilution without immediate compensation, a combination that rarely flatters existing shareholders. (source: SEC EDGAR 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/2100805/000162828026013633/0001628280-26-000079.htm)
If you’re after a chart route that visualises the gap between cash and income, the TradingView rail for JAN (Janus Living, Inc.) on the primary listing will show the price action against the company’s cash-per-share line. Remember: the chart reflects market narrative, not the income statement. (source: TradingView route, https://www.tradingview.com/symbols/JAN/) What’s missing is a clear, sourced bridge from the company’s $33.3 million quarterly operating cash flow to a demonstrably profitable net income figure, and an evidence-backed link between the equity plan’s incentives and operating performance. Until then, Janus Living remains a cash-rich story in search of a profit narrative.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
JAN technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on JAN
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep JAN research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
JAN FAQ
What is Janus Living, Inc. (JAN)?Janus Living, Inc. (JAN) has a latest verified close of 29.69, down 2.62%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...
Janus Living, Inc. (JAN) has a latest verified close of 29.69, down 2.62%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for JAN?Janus Living, Inc. (JAN) has a latest verified close of 29.69, down 2.62%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
Janus Living, Inc. (JAN) has a latest verified close of 29.69, down 2.62%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files JAN under USA Stocks for browsing.
How often is the JAN page updated?The JAN public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The JAN public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for JAN?The JAN file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:JAN. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The JAN file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:JAN. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on JAN?Yes. The workstation can open JAN, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open JAN, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this JAN page investment advice?No. The JAN page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The JAN page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
JAN
Equity · evidence first